Cabaletta Bio, Inc. (CABA)
↓ Download CSVKey ratios (FY2025)
-149.8%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | -$172.24M | -$125.14M | -$74.66M | -$54.14M | -$46.31M | -$33.83M | -$18.68M | -$6.19M | — |
| Net Income | -$167.86M | -$115.86M | -$67.67M | -$52.98M | -$46.29M | -$33.34M | -$16.94M | -$12.20M | — |
| EPS (Diluted) | $-2.10 | $-2.34 | $-1.65 | $-1.81 | $-1.80 | — | — | — | — |
| Total Assets | $165.08M | $185.05M | $253.65M | $116.97M | $126.34M | $114.72M | $141.47M | $34.17M | — |
| Total Liabilities | $53.03M | $32.71M | $17.45M | $12.45M | $8.38M | — | — | — | — |
| Shareholders' Equity | $112.05M | $152.34M | $236.20M | $104.52M | $117.96M | $109.54M | $138.32M | -$10.69M | -$249.0K |
| Cash & Equivalents | $82.98M | $163.96M | $193.24M | $81.61M | $122.22M | $101.43M | $136.20M | $33.02M | — |
| Operating Cash Flow | -$131.08M | -$88.22M | -$53.55M | -$46.38M | -$34.11M | -$26.77M | -$16.05M | -$4.66M | — |
| Capital Expenditures | $1.23M | $2.21M | $687.0K | $2.45M | $1.17M | $635.0K | $693.0K | — | — |
| Shares Outstanding | 100.48M | 50.74M | 47.82M | 29.45M | 28.93M | 24.06M | 24.03M | 3.85M | — |
| Dividends Per Share | — | — | — | — | — | — | $0.00 | — | — |